{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:24:26Z","timestamp":1761488666300},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1097\/inf.0b013e31821a0614","type":"journal-article","created":{"date-parts":[[2011,4,12]],"date-time":"2011-04-12T10:19:03Z","timestamp":1302603543000},"page":"e170-e178","source":"Crossref","is-referenced-by-count":36,"title":["Immunogenicity, Safety, and Reactogenicity of the 10-valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine and DTPa-IPV-Hib When Coadministered as a 3-dose Primary Vaccination Schedule in the Netherlands"],"prefix":"10.1097","volume":"30","author":[{"given":"Menno R.","family":"van den Bergh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Spijkerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Fran\u00e7ois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristien","family":"Swinnen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorota","family":"Borys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lode","family":"Schuerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinier H.","family":"Veenhoven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth A. M.","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-36-20210202","doi-asserted-by":"crossref","first-page":"5513","DOI":"10.1016\/j.vaccine.2010.06.026","article-title":"Glycoconjugate vaccines and immune interference: a review.","volume":"28","author":"Dagan","year":"2010","journal-title":"Vaccine"},{"key":"R2-36-20210202","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.vaccine.2009.01.005","article-title":"The influence of carrier protein on the immunogenicity of simultaneously administered conjugate vaccines in infants.","volume":"27","author":"P\u00f6llabauer","year":"2009","journal-title":"Vaccine"},{"key":"R3-36-20210202","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1586\/14760584.7.1.97","article-title":"Combination vaccines containing DTPa-Hib: impact of IPV and coadministration of CRM197 conjugates.","volume":"7","author":"Dagan","year":"2008","journal-title":"Expert Rev Vaccines"},{"key":"R4-36-20210202","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0140-6736(06)68304-9","article-title":"Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study.","volume":"367","author":"Prymula","year":"2006","journal-title":"Lancet"},{"key":"R5-36-20210202","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1086\/527396","article-title":"Protein D of Haemophilus influenzae: a protective nontypeable Hinfluenzae antigen and a carrier for pneumococcal conjugate vaccines.","volume":"46","author":"Forsgren","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R6-36-20210202","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1128\/IAI.00418-08","article-title":"Pneumococcal Haemophilus influenzae protein D conjugate vaccine induces antibodies that inhibit glycerophosphodiester phosphodiesterase activity of protein D.","volume":"76","author":"Toropainen","year":"2008","journal-title":"Infect Immun"},{"key":"R7-36-20210202","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1016\/j.vaccine.2005.11.021","article-title":"Assessment of the compatibility of co-administered 7-valent pneumococcal conjugate, DTaP. IPV\/PRP-T Hib and hepatitis B vaccines in infants 2\u20137 months of age.","volume":"24","author":"Scheifele","year":"2006","journal-title":"Vaccine"},{"key":"R8-36-20210202","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1016\/j.vaccine.2007.11.096","article-title":"Immunogenicity, reactogenicity, and safety of a seven-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a fully liquid DTPa-IPV-HBV-Hib combination vaccine in healthy infants.","volume":"26","author":"Olivier","year":"2008","journal-title":"Vaccine"},{"key":"R9-36-20210202","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1586\/erv.09.113","article-title":"10-valent pneumococcal nontypeable Haemophilus influenzae PD conjugate vaccine: Synflorix.","volume":"8","author":"Prymula","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"R10-36-20210202","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1097\/INF.0b013e318199f8ef","article-title":"Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine.","volume":"28","author":"Vesikari","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R12-36-20210202","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1097\/INF.0b013e318199f61b","article-title":"Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV).","volume":"28","author":"Knuf","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R13-36-20210202","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1128\/CDLI.8.2.266-272.2001","article-title":"Pneumococcal type 22F polysaccharide absorption improves the specificity of a pneumococcal-polysaccharide enzyme-linked immunosorbent assay.","volume":"8","author":"Concepcion","year":"2001","journal-title":"Clin Diagn Lab Immunol"},{"key":"R14-36-20210202","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1128\/CDLI.2.5.590-597.1995","article-title":"Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, lot 89-S.","volume":"2","author":"Quataert","year":"1995","journal-title":"Clin Diagn Lab Immunol"},{"key":"R15-36-20210202","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1128\/CVI.13.3.356-360.2006","article-title":"Critical differences between pneumococcal polysaccharide enyme-linked immunosorbent assays with and without 22F inhibition at low antibody concentrations in pediatric sera.","volume":"13","author":"Henckaerts","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"R16-36-20210202","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1128\/CVI.00289-09","article-title":"Evaluation of pneumococcal polysaccharide immunoassays using a 22F adsorption step with serum samples from infants vaccinated with conjugate vaccines.","volume":"17","author":"Poolman","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"R17-36-20210202","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1128\/CDLI.4.4.415-422.1997","article-title":"Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells.","volume":"4","author":"Romero-Steiner","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"key":"R18-36-20210202","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/BF02097184","article-title":"Acellular pertussis vaccine in adults: adverse reactions and immune response.","volume":"6","author":"Granstr\u00f6m","year":"1987","journal-title":"Eur J Clin Microbiol"},{"key":"R19-36-20210202","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-1759(87)90289-4","article-title":"Statistical considerations in the quantitation of serum immunoglobulin levels using the enzyme-linked immunosorbent assay (ELISA).","volume":"103","author":"Karpinski","year":"1987","journal-title":"J Immunol Methods"},{"key":"R20-36-20210202","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1128\/IAI.31.3.1223-1231.1981","article-title":"Role of antibody to leukocytosis-promoting factor hemagglutinin and to filamentous hemagglutinin in immunity to pertussis.","volume":"31","author":"Sato","year":"1981","journal-title":"Infect Immun"},{"key":"R22-36-20210202","first-page":"253","article-title":"Combined immunization of infants with oral and inactivated poliovirus vaccines: results from a randomized trial in the Gambia, Oman and Thailand.","year":"1996"},{"key":"R23-36-20210202","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1097\/INF.0b013e318199f62d","article-title":"Safety and reactogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with routine childhood vaccines.","volume":"28","author":"Chevallier","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R24-36-20210202","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1128\/JCM.20.4.772-774.1984","article-title":"Immunoenzymatic assay of anti-diphtheric toxin antibodies in human serum.","volume":"20","author":"Camargo","year":"1984","journal-title":"J Clin Microbiol"},{"key":"R25-36-20210202","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0092-1157(83)80038-9","article-title":"A comparison of enzyme-linked immunosorbent assay (ELISA) with the toxin neutralization test in mice as a method for the estimation of tetanus antitoxin in human sera.","volume":"11","author":"Melville-Smith","year":"1983","journal-title":"J Biol Stand"},{"key":"R26-36-20210202","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/S0140-6736(99)04377-9","article-title":"Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria-tetanus-pertussis containing acellular pertussis.","volume":"354","author":"Eskola","year":"1999","journal-title":"Lancet"},{"key":"R27-36-20210202","first-page":"1","article-title":"Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: recommendations of the Immunization Practices Advisory Committee (ACIP).","year":"1991","journal-title":"MMWR Recomm Rep"},{"key":"R28-36-20210202","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1056\/NEJM199505113321907","article-title":"Pathogenesis of pneumococcal infection.","volume":"349","author":"Tuomanen","year":"1995","journal-title":"N Engl J Med"},{"key":"R29-36-20210202","first-page":"443","article-title":"Progress in the Control of Viral Hepatitis: Memorandum for a WHO Meeting.","year":"1988"},{"key":"R30-36-20210202","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1586\/14760584.3.5.597","article-title":"Pneumococcal vaccine development.","volume":"3","author":"Poolman","year":"2004","journal-title":"Expert Rev Vaccines"},{"key":"R31-36-20210202","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1016\/j.vaccine.2006.09.029","article-title":"Validation of a routine opsonophagocytosis assay to predict invasive pneumococcal disease efficacy of conjugate vaccine in children.","volume":"25","author":"Henckaerts","year":"2007","journal-title":"Vaccine"},{"key":"R32-36-20210202","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/j.vaccine.2006.12.008","article-title":"ELISA IgG concentrations and opsonophagocytic activity following pneumococcal protein D conjugate vaccination and relationship to efficacy against acute otitis media.","volume":"25","author":"Schuerman","year":"2006","journal-title":"Vaccine"},{"key":"R33-36-20210202","doi-asserted-by":"crossref","first-page":"e276","DOI":"10.1097\/INF.0b013e3181b48ca3","article-title":"Immunogenicity of a 2-dose priming and booster vaccination with the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine.","volume":"28","author":"Silfverdal","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R34-36-20210202","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(09)61208-3","article-title":"Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trial.","volume":"374","author":"Prymula","year":"2009","journal-title":"Lancet"},{"key":"R35-36-20210202","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.vaccine.2009.10.151","article-title":"Comparability of antibody response to a booster dose of 7-valent pneumococcal conjugate vaccine in infants primed with either 2 or 3 doses.","volume":"28","author":"Rodenburg","year":"2010","journal-title":"Vaccine"},{"key":"R36-36-20210202","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1097\/INF.0b013e318199f609","article-title":"Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different Neisseria meningitidis serogroup C conjugate vaccines.","volume":"28","author":"Wysocki","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R37-36-20210202","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1097\/INF.0b013e318199f901","article-title":"The 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) coadministered with DTPw-HBV\/Hib and poliovirus vaccines: assessment of immunogenicity.","volume":"28","author":"Bermal","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R38-36-20210202","doi-asserted-by":"crossref","first-page":"7257","DOI":"10.1016\/j.vaccine.2009.09.111","article-title":"Estimating the direct impact of new conjugate vaccines against invasive pneumococcal disease.","volume":"27","author":"Hausdorff","year":"2009","journal-title":"Vaccine"},{"key":"R39-36-20210202","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1128\/IAI.72.9.5383-5391.2004","article-title":"Reduction of antibody response to an 11-valent pneumococcal vaccine coadministered with a vaccine containing acellular pertussis components.","volume":"72","author":"Dagan","year":"2004","journal-title":"Infect Immun"},{"key":"R41-36-20210202","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1128\/CVI.00431-08","article-title":"Development and technical and clinical validation of a quantitative enzyme-linked immunosorbant assay for the detection of human antibodies to hepatitis B surface antigen in recipients of recombinant hepatitis B virus vaccine.","volume":"16","author":"Cambron","year":"2009","journal-title":"Clin. Vaccine Immunol"},{"key":"R43-36-20210202","doi-asserted-by":"crossref","first-page":"e12144","DOI":"10.1371\/journal.pone.0012144","article-title":"Immunity against Neisseria meningitidis serogroup C in the Dutch population before and after introduction of the meningococcal C conjugate vaccine.","volume":"5","author":"de Voer","year":"2010","journal-title":"PLoS One"},{"key":"R44-36-20210202","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1086\/652765","article-title":"Antibody persistence after serogroup C meningococcal conjugate immunization of United Kingdom primary-school children in 1999\u20132000 and response to a booster dose: a phase 4 clinical trial.","volume":"50","author":"Perrett","year":"2010","journal-title":"Clin Infect Dis"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00006454-201109000-00036","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T05:59:47Z","timestamp":1618034387000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201109000-00036"}},"subtitle":["A Randomized Controlled Trial"],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e31821a0614","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}